MNA
ARIA

Manning & Napier Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Manning & Napier Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-504,530
Closed -$9.28M – 351
2013
Q3 		$9.28M Buy
+504,530
New +$9.8M 0.04% 166

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Manning & Napier Advisors's ARIA Position: Q4 2013 in Review

Manning & Napier Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2013, closing a stake of 504,530 shares — an estimated $9.28M sold.

Manning & Napier Advisors first reported a position in ARIA in Q3 2013 and held it in 1 quarter. The position peaked at $9.28M in Q3 2013. 166 funds tracked by Wall St. Rank hold ARIA as of Q4 2013.

  • Manning & Napier Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Manning & Napier Advisors sold 504,530 Ariad Pharmaceuticals Inc shares in Q4 2013, an estimated $9.28M.
  • Manning & Napier Advisors first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 1 quarter.
  • Manning & Napier Advisors's Ariad Pharmaceuticals Inc position peaked at $9.28M in Q3 2013.
  • 166 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2013.

Based on Manning & Napier Advisors's 13F filing for Q4 2013, filed 29 Jan 2014.